-
New Biomarkers of Inflammation Identified as Risk Factors for Neuropathy
24.08.2018 · DDZ Deutsches Diabetes-ZentrumAlthough many patients suffer from polyneuropathy, relatively little is currently known about its development, which also limits the therapeutic options. It is known that inflammatory processes contribute to other diabetic...
-
A molecular switch may serve as new target point for cancer and diabetes therapies
13.08.2018 · FMP Leibniz-Forschungsinstitut für Molekulare PharmakologieIf certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A mechanism recently discovered by scientists at the Leibniz- Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin...
-
Alexander von Humboldt Research Fellow at FLI
13.08.2018 · FLI Leibniz Institute on Aging - Fritz Lipmann InstituteUkrainian cell biologist Dr. Yuliya Kurlishchuk has received a research fellowship for postdocs from the Alexander von Humboldt Foundation. With this funding, she is now a guest at the Leibniz Institute on Aging – Fritz Lipmann...

Issue 08
Healthy Ageing - Forschung aus erster Hand
.
Bioactive compound improves memory
.
Better understanding cardiovascular diseases